Skip to main content

Pain Management Devices Market Worth USD 4.64 Billion | New Technologies for Pain Management


A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global pain management devices market.

Pain management device are used to manage chronic and acute pain in patients suffering from various conditions, such as cancer, neurological disorders, and musculoskeletal disorders. These devices restore the ability of patients to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions.

The global pain management devices market is valued at an estimated USD 4.64 Billion in 2021 and is projected to grow at a CAGR of 8.5%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91418163

Regional Growth Analysis:

The Asia-Pacific region has become an attractive destination for companies engaged in the manufacture of pain management device. The high growth opportunities in this regional segment can be attributed to a number of factors, including growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and rising awareness about the safety and efficacy of pain management device. According to the U.S. Department of Commerce, Japan has one of the largest geriatric populations in the world, with at least 20% of its population aged 65 years and above. In 2012, 30 million people in Japan were aged above 65 years and this figure is projected to reach 39 million by 2030 and nearly 43 million by 2050. Driven by its high growth potential, leading companies operating in the market are focusing on expanding their presence in emerging APAC countries.

Pain Management Devices Market Application:

On the basis of applications, the pain management devices market is segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and other applications (pregnancy/labor and menstrual pain, sports injuries, post-operative pain, and trauma pain). The neuropathic pain segment is estimated to witness the highest growth during the forecast period, primarily due to the high prevalence of diseases resulting in neuropathic pain.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=91418163

Key Players in Pain Management Equipment Market:


Leading players in the pain management devices market are focusing on the strategies of new product launch and geographic expansion. These strategies help market players to strengthen their product portfolios, streamline their manufacturing capabilities, expand their distribution networks, and penetrate into high-growth markets.
Some of the Major Key Players From Pain Management Devices Market are Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.) were the top players in the in 2015.

Comments

Popular posts from this blog

Dental Bone Graft Substitutes Market worth $664.3 Million by 2021

According to a new market research report  " Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" , published by MarketsandMarkets, The global market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts. This report mainly considers four type

Ostomy Care Accessories Market

The global ostomy care accessories market is projected to reach USD 2.99 billion by 2022 from USD 2.40 billion in 2017, at the CAGR of 4.5%. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of this market. The ostomy care accessories market is expected to grow at the highest CAGR during the forecast period owing to the growing skin problems due to frequent removal and re-application of skin barrier of ostomy bags and rising awareness about care of peristomal skin. Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=267183143 By system, the ostomy bags market is segmented into one-piece, two-piece, and skin barrier. Two-piece bags are expected to hold the

Cartilage Regeneration Market | Growth and Analysis, Industry Trends, Size, Shares, Forecast

The global  cartilage regeneration market  is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of cartilage regeneration market. However, high cost of therapy and unfavorable reimbursement scenario are the major factors that are restraining the growth of the market. The cartilage regeneration market is segmented on the basis of treatment modalities, application, and region. Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share i